Alyeska Investment Group, L.P. Leap Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$1.35 - $4.01 $460,128 - $1.37 Million	340,836 Added 658.44%	392,600 $1.57 Million
Q1 2021 May 17, 2021	SELL	$1.82 - $3.01 $109,500 - $181,096	-60,165 Reduced 53.75%	51,764 $98,000
Q4 2020 Feb 16, 2021	BUY	$1.49 - $2.37 $19 - $30	13 Added 0.01%	111,929 $251,000
Q3 2020 Nov 16, 2020	SELL	$1.68 - $2.17 $2.32 Million - $3 Million	-1,382,603 Reduced 92.51%	111,916 $221,000
Q2 2020 Aug 14, 2020	BUY	$1.39 - $2.84 $2.08 Million - $4.24 Million	1,494,519 New	1,494,519 $3.12 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.